
Pharmaceutical Representative
An increasing number of physicians in the United States are choosing to practice in medical group settings, according to a study published by the AMA.

Pharmaceutical Representative
An increasing number of physicians in the United States are choosing to practice in medical group settings, according to a study published by the AMA.

Pharmaceutical Representative
New drug treatments are offering hope to patients who suffer from autism, compulsive buying and hypochondria, according to one expert in the field.

Pharmaceutical Representative
Patients and professionals who want more information on breast cancer have a new resource on the Internet's World Wide Web.

Pharmaceutical Representative
Two researchers have published new guidelines for managed care systems to evaluate drug products.

Pharmaceutical Representative
Not long after the Olympic athletes took their medals home from Atlanta last summer, one area pharmaceutical company won another kind of competition.

Pharmaceutical Representative
Pharmaceutical Representative recently asked members of its Reader Advisory Panel to describe their new year's resolutions. If you're thinking about making a resolution, these examples may give you some good ideas.

Pharmaceutical Representative
FDA Commissioner David Kessler, M.D., is leaving after six years at the agency

Pharmaceutical Representative
Pharmaceutical Representative recently asked industry experts to predict the future. The following are their responses about the coming year.

Pharmaceutical Representative
Psychiatrists have developed new clinical guidelines for treating bipolar disorder and schizophrenia.

Pharmaceutical Executive
We asked top intellectual property lawyers about what the Supreme Courts decision will mean for pharma and biotech companies. Here is our forward-looking analysis of their comments.